Last reviewed · How we verify
NCT07372547
Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery
NA trial testing Voiding position - Standing in the shower in Post-void Residual Volume in 100 participants. Currently enrolling.
20 January 2028
Quick facts
| Lead sponsor | Assuta Ashdod Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 20 January 2026 |
| Primary completion | 20 January 2028 |
| Estimated completion | 20 January 2028 |
| Sites | 2 locations across Israel |
Drugs / interventions tested
- Voiding position - Standing in the shower
- Voiding position - Sitting on the toilet
Conditions studied
- Post-void Residual Volume — all drugs for Post-void Residual Volume →
- Recatheterization — all drugs for Recatheterization →
- Pain — all drugs for Pain →
- UTI — all drugs for UTI →
Sponsor
Assuta Ashdod Hospital
Who can join
Adults 18 to 99, female only, with Post-void Residual Volume or Recatheterization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07372547
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Assuta Ashdod Hospital trials
Trials by the same sponsor.
- NCT05941390 — Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures · NA · unknown
- NCT05448456 — Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail · Phase 4 · completed
- NCT06009679 — MISOPROSTOL FOR THE TREATMENT OF SUSPECTED POSTPARTUM RETAINED PRODUCTS OF CONCEPTION · NA · unknown
- NCT04210908 — Biofeedback for Second Stage of Labor · NA · completed
- NCT04512820 — Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07372547 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assuta Ashdod Hospital
- Last refreshed: 25 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07372547.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing